Advanced Therapies Europe 2025

Advanced Therapies Europe 2025 will take place from September 2 to 4, 2025, at the Hotel Arts Barcelona (Spain) and will be organized by Phacilitate.

They join 500 of the most influential minds in cell and gene therapy for a high-impact, curated experience in Barcelona — one of Europe’s fastest-growing biotech hubs. Across three days of expert content, strategic networking, and invite-only summits, Advanced Therapies Europe 2025 connects therapeutic developers, pharma leaders, CDMOs, and investors in one focused environment.

From plenary sessions and technical workshops to the Women in Advanced Therapies Congress and Investment Summit, every element is designed to accelerate innovation, investment, and commercialisation across the advanced therapies landscape.

Whether you're launching a new therapy, seeking strategic partnerships, or staying ahead of regulatory and market shifts, Advanced Therapies Europe is built to deliver actionable insight and meaningful connections.

• Expand Your Network – Meet biotech CEOs, pharma strategists, CDMO leaders, and investors shaping the next wave of therapeutic innovation.
   
• Gain Strategic Insight – Access sessions led by industry experts on regulation, funding trends, scale-up solutions, and commercial strategy.
   
• Discover What’s Next – Explore the latest advances in cell and gene therapy platforms, biotech technologies, and regenerative medicine.

Ahead of Phacilitate’s Advanced Therapies Europe, they join key industry experts to discuss the current state and trajectory of ATMPs in the EU.

As the world has seen seismic shifts in the funding, technical, and commercial landscape for cell and gene therapies, they recognize the importance of identifying Europe’s evolving role in the global ecosystem, and how they can establish and shore up European bioregions that can translate, develop, and manufacture the next generation of ATMPs.

This is a must-attend, plenary-level meeting for translational, technical, and commercial cell and gene therapy experts.

When?
Thursday, July 10, 2025 · 1:30 p.m.

Speakers:

• Lindsay Davies, CEO. NextCell
• Miguel Forte, CEO. Kiji Therapeutics
• Montse Daban, Director of Science Policy & Internalization. Biocat

Fireside chat: From Seed to scale – How we built an investor-ready biotech

A candid conversation between a biotech founder and their early investor exploring the startup journey.

02/09/2025

10:50 AM - 11:20 AM

Hotel Arts, Barcelona (Spain)

Speakers:

• Sylvain Sachot, Partner. Asabys Partners
• Miquel Vila-Perelló, CEO. Splice Bio
   

Panel: Trends talk – Emerging hotspots in biotech investing

A rapid-fire panel / multi-perspective session on high-growth areas in biotech. Each speaker gives a 5-minute outlook on where their focus and how this aligns with market trends.

02/09/2025

12:10 AM - 12:50 AM

Hotel Arts, Barcelona (Spain)

Speakers:

• Anni Moro, Co-founder & CEO. StemSight
• Artemy Shumisky, Senior Associate. LongeVC
• Luis Pareras, Managing Partner. Invivo Partners
• Ilya Yasny, Partner. LanceBio Ventures
   

Opening Panel: Rethinking access and advancement within the advanced therapies industry

Explore the complex mix of visible and invisible barriers that shape entry into the industry. Address systemic challenges and how we can create a truly inclusive workforce.

02/09/2025

2:05 PM - 2:45 PM

Hotel Arts, Barcelona (Spain)

Speakers:

• Avencia Sanchez-Mejias, CEO & Co-founder. Integra Therapeutics
• Keren Leshem, CEO & Interim Chair. OCON Therapeutics
• Kat Kozyrytska, Founder. Cell Therapy Manufacturability Program
• Mayra Battilani, Former EMEA – Commercial Strategy Director Gene Therapy – Rare Diseases. Johnson & Johnson
   

Roundtable 5: How to be a good mentor – and find one

02/09/2025

3:25 PM - 4:10 PM

Hotel Arts, Barcelona (Spain)

Speakers:

• Alessandra Magnani, Head of the Advanced Therapies and Immunotherapy Platform. Hospital Sant Joan de Déu
   

Spain’s Biotech Leap: Manufacturing, Clinical Capacity & EU Integration

Explore Spain’s growing potential as a strategic ATMP manufacturing and clinical trial hub within the EU.

03/09/2025

12:15 AM - 12:45 AM

Hotel Arts, Barcelona (Spain)

Speakers:

• Montse Daban, Executive Director. Biocat
• Gerard Caelles, Chief Business Officer. SpliceBio
• Stefanos Theoharis, Chief Executive Officer. OneChain Therapeutics
• Claudio Santos, CEO. Gyala Therapeutics
   

Panel: From discovery to development – Creating realistic CGT timelines

The transition from academic scientific concept to market-ready product requires biotech teams to integrate CMC, regulatory, and pharmacology considerations from the outset, thereby avoiding the pitfalls of overselling and overpromising.

03/09/2025

2:00 PM - 2:30 PM

Hotel Arts, Barcelona (Spain)

Speakers:

• Anne Douar, Principal & Founder. Ad hoc Biologics
• John Campbell, CSO. Swarm Oncology
• Elena Matsa, Professor. University College Cork
• Alessandra Magnani, Head of the Advanced Therapies and Immunotherapy Platform. Hospital Sant Joan de Déu
• Claudio Santos, CEO. Gyala Therapeutics

20% discount for companies and organizations in the BioRegion of Catalonia using the code BIOCAT20 at registration